Lumida
/IBEX
⌘K
Ibex Ltd

Ibex Ltd

IBEX
$39.80USD+6.82%+2.54 today

MARKET CAP

532.9M

P/E (TTM)

12.4x

FWD P/E

DAY RANGE

$32 – $40

52W RANGE

$26
$43

AI Summary

Stalk
StalkMedium

IBEX remains in an early Stage 1 consolidation within a long-term uptrend. Price has repaired its 9/21 EMA regime and is range-bound, suggesting cautious accumulation. Medium-term directional bias is modestly bullish, but short-term timing is neutral, warranting deferred execution into pullbacks around EMA support.

  • Q3 FY26 revenue $164.4M (+17% YoY); adjusted EPS $0.91 (+11% YoY).
  • Health tech vertical revenue +54% YoY drives high margins.
  • Capital expenditures rising to $25–30M could pressure margins.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$443.4M$492.9M$523.1M$508.6M$558.3M
YoY %+11.2%+6.1%-2.8%+9.8%
P / Sales0.8x0.6x0.8x0.6x0.8x
EV / Sales0.8x0.9x0.9x0.7x1.0x
Gross Profit, Adj.$108.1M$118.9M$148.1M$152.0M$172.6M
YoY %+9.9%+24.6%+2.6%+13.5%
Margin %24.4%24.1%28.3%29.9%30.9%
EV / Gross Profit3.3x3.8x3.3x2.3x3.4x
EBITDA, Adj.$43.1M$38.7M$59.5M$58.9M$63.8M
YoY %-10.2%+53.6%-1.0%+8.4%
Margin %9.7%7.9%11.4%11.6%11.4%
EV / EBITDA8.3x11.6x8.2x6.1x9.1x
EBIT$17.0M$20.6M$40.5M$39.4M$46.6M
YoY %+21.0%+96.3%-2.6%+18.2%
Margin %3.8%4.2%7.7%7.8%8.3%
EV / EBIT21.0x21.7x12.0x9.0x12.5x
Net Income$13.1M$21.5M$31.6M$33.7M$36.9M
YoY %+63.9%+47.2%+6.6%+9.5%
Net Margin3.0%4.4%6.0%6.6%6.6%
EPS (GAAP)$0.71$1.15$1.67$1.84$2.36
YoY %+62.0%+45.2%+10.2%+28.3%